Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia-Reference-Cited by-同舟云学术

Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia

Published:2006-01-01 Issue:1 Volume:106 Page:120-127
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Thomas Deborah A.,Sarris Andreas H.,Cortes Jorge,Faderl Stefan,O'Brien Susan,Giles Francis J.,Garcia-Manero Guillermo,Rodriguez Maria A.,Cabanillas Fernando,Kantarjian Hagop

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference47 articles.

1. Clinical Studies with Vincristine

2. The binding of vincristine, vinblastine and colchicine to tubulin

3. Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes

4. Cell death induced by vincristine in the intestinal crypts of mice and in a human Burkitt's lymphoma cell line

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pomegranate extract-loaded sphingosomes for the treatment of cancer: Phytochemical investigations, formulation, and antitumor activity evaluation;PLOS ONE;2024-02-12

2. Review on novel targeted enzyme drug delivery systems: enzymosomes;Soft Matter;2024

3. Anatomical Targeting of Anticancer Drugs to Solid Tumors Using Specific Administration Routes: Review;Pharmaceutics;2023-06-06

4. Review on Different Vesicular Drug Delivery Systems (VDDSs) and Their Applications;Recent Patents on Nanotechnology;2023-03

5. Theranostic Applications of Functionalized Vesicular Carriers;Multifunctional And Targeted Theranostic Nanomedicines;2023